Exhibitor Tutorial

A TR-FRET approach to measure the kinetics of ligand-receptor binding and its application to kinetic fragment screening

Tuesday, February 6
12:30 PM - 1:15 PM
Location: Room 5A

Optimizing the receptor binding kinetics of new drugs can have significant benefits, ranging from improved duration of action to enhanced efficacy through the insurmountable antagonism of dynamic physiological systems. It is also becoming apparent that binding kinetics plays a role in the phenomenon of biased agonism. Despite this, the kinetics of new receptor ligands are rarely measured early in the drug discovery process, largely because current assays are technically difficult and relatively low-throughput.
This talk will introduce the potential clinical benefits of optimising binding kinetics and review the current methods for measuring kinetic parameters. It will then describe the development of a novel approach using time-resolved FRET in continuous read mode that is capable of simultaneously measuring the kinetics of hundreds of compounds. This enables kinetics assays to be placed at the top of a screening cascade, negating the need to first run “IC50 curves” to assess affinity at the receptor. It also offers the opportunity to measure the kinetics of low affinity compounds, making it an ideal platform for fragment screening. This will be exemplified by describing a fragment screening campaign that was recently run in kinetic mode at the dopamine D2 receptor.

Carl Peters

Senior Applications Scientist
BMG Labtech

Dr. Carl Peters is a microplate reader Senior Application Scientist with BMG LABTECH. He obtained a PhD in Cell and Molecular Biology from Northwestern University while studying Protein Kinase C signaling. He also has a B.S. in Biology from Hastings College. Prior to BMG LABTECH, he was an adjunct or assistant professor of Biology, Biochemistry and Molecular Biology at several different universities.

Presentation(s):

Send Email for Carl Peters

Catherine Wark

Senior Applications Scientist
BMG LABTECH Ltd.

Catherine Wark is a Senior Applications Scientist with BMG LABTECH based in UK. She has fifteen years’ experience with BMG LABTECH, assisting users with microplate reader and assay optimization, drawing from her previous experiences in both academia and industry working in the fields of cell and molecular biology.

Presentation(s):

Send Email for Catherine Wark

Steven Charlton

Professor of Molecular Pharmacology and Drug Discovery
School of Life Sciences, Queen's Medical Centre, University of Nottingham

Presentation(s):

Send Email for Steven Charlton


Assets

A TR-FRET approach to measure the kinetics of ligand-receptor binding and its application to kinetic fragment screening



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for A TR-FRET approach to measure the kinetics of ligand-receptor binding and its application to kinetic fragment screening